Advanced MRI Techniques for Healthy Subjects

N/A

Waitlist Available

Led By Oguz Akin, MD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Female patients/ volunteers who are pregnant or nursing

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing whether new MRI methods can improve how images are obtained.

Who is the study for?

This trial is for men and women aged 18 or older who are in good health. It's not suitable for pregnant or nursing women, those considered vulnerable by specific regulations, anyone with conditions that make MRI unsafe like pacemakers, or individuals unable to complete an MRI due to anxiety issues.

What is being tested?

The study is testing new techniques of Magnetic Resonance Imaging (MRI) acquisition and analysis. The aim is to improve how MRI images are captured using updates in software and hardware, potentially benefiting research and patient care.

What are the potential side effects?

Since the intervention involves standard MRI procedures with potential updates in technique, side effects may include discomfort from lying still during the scan or loud noises from the machine. There's no exposure to radiation.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am currently pregnant or nursing.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

feasibility of new MRI applications

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: MRIExperimental Treatment2 Interventions

Add-On Research Patients will include patients who are scheduled for a routine clinical MRI who meet the eligibility requirements for this protocol. Protocol participation will consist of an "add-on" research. MRI scan, which will be performed any point during of the routine clinical MRI scan. Volunteers will be subjects expressing interest in participation and who meet the eligibility requirements for this protocol. No contrast enhanced research MRIs including gadolinium-based or other contrast agents will be performed in volunteers.

0 / 1Eligibility criteria met